Research Appraisalother

Self-Paced Learning for Images of Antinuclear Antibodies

IEEE transactions on medical imagingJiang, Yiyang, Qian, Guangwu, Wu, Jiaxin et al.1 Apr 2026DOI

Clinical Snapshot

85CEBM
Evidence: Moderateother

PICO Framework

P — PopulationMicroscope images of antinuclear antibody (ANA) fluorescent patterns from clinical specimens
I — InterventionNovel self-paced learning framework with instance sampler, probabilistic pseudo-label dispatcher, and adaptive weight learning
C — ComparatorTraditional multi-instance multi-label (MIML) methods and existing automated ANA detection approaches
O — OutcomesF1-Macro score, mean average precision (mAP), Hamming loss, one-error rate, and overall diagnostic accuracy

Bottom Line

This methodological study presents a novel self-paced learning framework for automated antinuclear antibody detection that addresses the complex multi-instance, multi-label nature of ANA pattern recognition. The framework achieved substantial performance improvements (+7.0% F1-Macro, +12.6% mAP) over existing methods while working with unaltered microscope images. For Australian pathology services, this technology could significantly improve efficiency and standardization of ANA testing, which is critical for diagnosing autoimmune conditions like lupus and Sjögren's syndrome. However, clinical validation in real-world laboratory settings is needed before implementation. The approach shows promise for reducing the labor-intensive nature of ANA interpretation while potentially improving diagnostic accuracy, though careful validation of performance across different laboratory protocols and patient populations will be essential.

Evidence: Moderate

Key Findings

  • P Value: Not reported in abstract

  • Effect Size: +7.0% F1-Macro improvement, +12.6% mAP improvement over best prior method

  • Primary Outcome: F1-Macro score improvement for ANA pattern detection

  • Nnt Or Sensitivity: Up to 26.9% reduction in one-error rate, 18.2% reduction in Hamming loss

  • Confidence Interval: Not reported in abstract

Clinical Application

Requires implementation of deep learning infrastructure but designed for unaltered microscope images Highly relevant to Australian pathology services given PBS coverage for ANA testing and RCPA guidelines for autoimmune diagnostics. Could improve efficiency and standardization across laboratories. Pathology laboratories performing ANA testing for autoimmune disorder diagnosis

Abstract

Antinuclear antibody (ANA) testing is a critical method for diagnosing autoimmune disorders such as Lupus, Sjögren's syndrome, and scleroderma. Despite its importance, manual ANA detection is slow, labor-intensive, and demands years of training. ANA detection is complicated by over 100 coexisting antibody types, resulting in vast fluorescent pattern combinations. Although machine learning and deep learning have enabled automation, ANA detection in real-world clinical settings presents unique challenges as it involves multi-instance, multi-label (MIML) learning. In this paper, a novel framework for ANA detection is proposed that handles the complexities of MIML tasks using unaltered microscope images without manual preprocessing. Inspired by human labeling logic, it identifies consistent ANA sub-regions and assigns aggregated labels accordingly. These steps are implemented using three task-specific components: an instance sampler, a probabilistic pseudo-label dispatcher, and self-paced weight learning rate coefficients. The instance sampler suppresses low-confidence instances by modeling pattern confidence, while the dispatcher adaptively assigns labels based on instance distinguishability. Self-paced learning adjusts training according to empirical label observations. Our framework overcomes limitations of traditional MIML methods and supports end-to-end optimization. Extensive experiments on one ANA dataset and three public medical MIML benchmarks demonstrate the superiority of our framework. On the ANA dataset, our model achieves up to +7.0% F1-Macro and +12.6% mAP gains over the best prior method, setting new state-of-the-art results. It also ranks top-2 across all key metrics on public datasets, reducing Hamming loss and one-error by up to 18.2% and 26.9%, respectively. The source code can be accessed at https://github.com/fletcherjiang/ANA-SelfPacedLearning.

References

  1. 1.Jiang, Y., Qian, G., Wu, J., Huang, Q., Li, Q., Wu, Y., & Wei, X.-Y. (2026). Self-Paced Learning for Images of Antinuclear Antibodies. IEEE Transactions on Medical Imaging. https://doi.org/10.1109/TMI.2025.3637237
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service